Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Salivary Gland Neoplasms × CTLA-4 Antigen × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Neoplasm Metastasis 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Rectal Neoplasms 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Pheochromocytoma 1 Perivascular Epithelioid Cell Neoplasms 1 Parathyroid Neoplasms 1 Paranasal Sinus Neoplasms 1 Paraganglioma 1 Paget Disease, Extramammary 1

Interventions

Carboplatin 3 trastuzumab deruxtecan 2 Docetaxel 2 Cisplatin 2 zanidatamab 1 sacituzumab govitecan 1 pembrolizumab 1 entrectinib 1 dehydroftorafur 1 ceralasertib 1 Specimen Handling 1 Sorafenib 1 Radiation 1 Platinum 1 Oral Hygiene 1 Maytansine 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Cetuximab 1 Biopsy 1 Bevacizumab 1 Ado-Trastuzumab Emtansine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡